...
首页> 外文期刊>Clinical neuropathology >Expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple system atrophy.
【24h】

Expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple system atrophy.

机译:内吞调节蛋白Rab5和Rabaptin-5在具有多系统萎缩的大脑胶质细胞内含物中表达。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Glial cytoplasmic inclusions (GCIs) occur specifically in oligodendrocytes in brains with multiple system atrophy (MSA). Oligodendrocytes in MSA appear to be functionally altered in their nature in terms of the occurrence of GCIs and aberrant expression of various proteins such as neuron specific protein, MAP2 or pre-synaptic protein, ct-synuclein. The present study examined whether or not aberrant expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 occcur in oligodendrocytes of brains with MSA. MATERIALS AND METHODS: We examined immunohistochemically the post-mortem brain tissues from 5 patients with MSA and 5 controls. Immunohistochemistry was done using monoclonal anti-Rab5 and anti-Rabaptin-5 antibodies based on ABC method. RESULTS: We have observed Rab5 and Rabaptin-5 immunoreactivity in the neuronal somata and axons of the controls, suggesting that Rab5 and Rabaptin-5 are involved in the regulation of the endocytosis in neurons of the human central nervous system. In the brain tissues from patients with MSA, we have found Rab5 and Rabaptin-5 immunoreactivity in GCIs. CONCLUSION: Rab5, in association with Rabaptin-5, has been demonstrated in the early endosome and regulates the endocytosis. Since Rab5 and Rabaptin-5 have been immunolocalized to neurons in the human brains, we propose that oligodendrocytes may ectopically express Rab5 and Rabaptin-5 in MSA. Thus, the oligodendrocytes in MSA brains appear to be functionally significantly altered, which may be associated with the formation of GCIs in the oligodendrocytes.
机译:背景:神经胶质细胞质内含物(GCIs)特别存在于多系统萎缩(MSA)的大脑少突胶质细胞中。就GCI的出现和各种蛋白质(例如神经元特异性蛋白质,MAP2或突触前蛋白质,ct-突触核蛋白)的异常表达而言,MSA中的少突胶质细胞本质上似乎在功能上发生了改变。本研究检查了患有MSA的大脑少突胶质细胞中是否存在内吞调节蛋白Rab5和Rabaptin-5的异常表达。材料与方法:我们用免疫组织化学方法检测了5名MSA患者和5名对照的死后脑组织。免疫组织化学使用基于ABC方法的单克隆抗Rab5和抗Rapaptin-5抗体进行。结果:我们在对照的神经细胞体和轴突中观察到Rab5和Rabaptin-5免疫反应性,表明Rab5和Rabaptin-5参与了人类中枢神经系统神经元内吞作用的调节。在MSA患者的脑组织中,我们发现GCI中具有Rab5和Rabaptin-5免疫反应性。结论:Rab5与Rabaptin-5结合,已在早期的内体中被证实并调节内吞作用。由于Rab5和Rabaptin-5已被免疫定位到人脑中的神经元,因此我们建议少突胶质细胞可能在MSA中异位表达Rab5和Rabaptin-5。因此,MSA脑中的少突胶质细胞似乎在功能上发生了明显改变,这可能与少突胶质细胞中GCI的形成有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号